What Happened?
South San Francisco, CA-based Second Genome Appointed Peter DiLaura as Chief Executive Officer
About the Company
Second Genome is a clinical stage company with a mission to improve human health by unlocking the full potential of the microbiome. We offer the most robust approach to microbiome drug discovery and development through the deepest understanding of how the microbiome works in human health.
About the Person
Peter DiLaura is Chief Executive Officer at Second Genome. Previously, Peter held various senior HR leadership roles in the industry.
Info Source
News
Short Profile